Lite Strategy, Inc. Shareholders' Equity
Lite Strategy, Inc. (LITS) had Shareholders' Equity of $56.84 million as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-05-13
- 2026-03-31: Stockholders' Equity Attributable to Parent $56.84M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $81.85M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $112.27M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $16.93M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-03-31 | $56.84M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $81.85M 10-Q · filed 2026-05-13 | |
| 2025-09-30 | $112.27M 10-Q · filed 2026-05-13 | |
| 2025-06-30 | $16.93M 10-Q · filed 2026-05-13 | |
| 2025-03-31 | $19.54M 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $22.10M 10-Q · filed 2026-05-13 | |
| 2024-09-30 | $24.88M 10-Q · filed 2026-05-13 | |
| 2024-06-30 | $33.02M 10-Q · filed 2026-05-13 | |
| 2024-03-31 | $51.03M 10-Q · filed 2025-05-13 | |
| 2023-12-31 | $59.49M 10-Q · filed 2025-05-13 | |
| 2023-09-30 | $81.36M 10-Q · filed 2025-05-13 | |
| 2023-06-30 | $24.62M 10-K · filed 2025-09-26 | |
| 2023-03-31 | $34.35M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $48.37M 10-Q · filed 2024-05-09 | |
| 2022-09-30 | $37.31M 10-Q · filed 2024-05-09 | |
| 2022-06-30 | $52.41M 10-K · filed 2024-09-19 | |
| 2022-03-31 | $67.81M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $73.33M 10-Q · filed 2023-05-11 | $77.25M 10-Q · filed 2022-02-10 |
| 2021-09-30 | $34.30M 10-Q · filed 2023-05-11 | $31.83M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $49.47M 10-K · filed 2023-09-26 | $41.36M 10-K · filed 2021-09-02 |
| 2021-03-31 | $55.73M 10-Q · filed 2022-05-23 | $44.96M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $78.57M 10-Q/A · filed 2022-05-23 | $73.50M 10-Q · filed 2021-02-04 |
| 2020-09-30 | $83.97M 10-Q/A · filed 2022-05-23 | $82.33M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $77.06M 10-K · filed 2022-09-08 | $78.22M 10-K · filed 2020-09-09 |
| 2020-03-31 | $74.50M 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $77.28M 10-Q · filed 2021-05-06 | |
| 2019-09-30 | $47.28M 10-Q · filed 2021-05-06 | |
| 2019-06-30 | $47.93M 10-K · filed 2022-09-08 | |
| 2019-03-31 | $37.88M 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $53.47M 10-Q · filed 2020-05-07 | $53.47M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $39.76M 10-Q · filed 2020-05-07 | |
| 2018-06-30 | $50.46M 10-K/A · filed 2022-05-23 | |
| 2018-03-31 | $32.91M 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $38.36M 10-Q · filed 2019-05-09 | |
| 2017-09-30 | $43.57M 10-Q · filed 2019-05-09 | |
| 2017-06-30 | $50.84M 10-K · filed 2020-09-09 | |
| 2017-03-31 | $54.90M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $54.89M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $42.33M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $41.65M 10-K · filed 2019-08-28 | |
| 2016-03-31 | $46.91M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $51.64M 10-Q · filed 2016-02-05 | |
| 2015-09-30 | $55.94M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $59.79M 10-K · filed 2018-08-30 | |
| 2015-03-31 | $64.96M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $72.86M 10-Q · filed 2015-02-06 | |
| 2014-09-30 | $37.61M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $45.19M 10-K · filed 2017-09-05 | |
| 2014-03-31 | $52.52M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $58.73M 10-Q · filed 2014-02-11 | |
| 2013-09-30 | $31.15M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $34.87M 10-K · filed 2016-09-06 | |
| 2013-03-31 | $23.16M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $25.79M 10-Q · filed 2013-02-12 | |
| 2012-09-30 | $2.73M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $4.60M 10-K · filed 2015-09-02 | |
| 2012-03-31 | $1.79M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $3.93M 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $3.35M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $1.79M 10-K · filed 2014-09-09 | |
| 2010-06-30 | $7.38M 10-K · filed 2013-09-18 | |
| 2009-06-30 | $15.21M 10-K · filed 2013-09-18 | |
| 2008-06-30 | $16.54M 10-K · filed 2013-09-18 | |
| 2007-06-30 | $13.78M 10-K · filed 2013-09-18 | |
| 2006-06-30 | $9.13M 10-K · filed 2013-09-18 | |
| 2005-06-30 | $16.52M 10-K · filed 2013-09-18 | |
| 2004-06-30 | $22.94M 10-K · filed 2013-09-18 | |
| 2003-06-30 | $5.93M 10-K · filed 2013-09-18 | |
| 2002-06-30 | $8.90M 10-K · filed 2013-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |